| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| FIHLFidelis Insurance Holdings Limited | 1.92B | 18.60 | 18.98 | -32.59% | -0.58% | -0.6% | 32.02% | 0.18 |
| ACGLArch Capital Group Ltd. | 32.98B | 90.94 | 8.13 | 27.35% | 21.5% | 17.27% | 20.08% | 0.13 |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Revenue | 782.6M | 1.19B | 1.52B | 3.59B | 2.42B |
| Revenue Growth % | - | 0.53% | 0.27% | 1.37% | -0.33% |
| Medical Costs & Claims | 503.7M | 946.9M | 0 | 1.42B | 2.16B |
| Medical Cost Ratio % | - | - | - | - | - |
| Gross Profit | 278.9M | 247.5M | 1.52B | 2.17B | 266.1M |
| Gross Margin % | - | - | - | - | - |
| Gross Profit Growth % | - | -0.11% | 5.13% | 0.43% | -0.88% |
| Operating Expenses | 155.4M | 168.8M | 1.44B | 122.3M | 129.7M |
| OpEx / Revenue % | - | - | - | - | - |
| Depreciation & Amortization | 2.6M | 4.5M | 3.9M | 300K | -14M |
| Combined Ratio % | - | - | - | - | - |
| Operating Income | 123.5M | 78.7M | 80.1M | 2.05B | 136.4M |
| Operating Margin % | - | - | - | - | - |
| Operating Income Growth % | - | -0.36% | 0.02% | 24.56% | -0.93% |
| EBITDA | 126.1M | 83.2M | 84M | 2.05B | 122.4M |
| EBITDA Margin % | - | - | - | - | - |
| Interest Expense | 27.9M | 35.4M | 35.5M | 35.5M | 33.8M |
| Non-Operating Income | -27.9M | -35.4M | -35.5M | -35.5M | -33.8M |
| Pretax Income | 123.5M | 78.7M | 80.1M | 2.05B | 136.4M |
| Pretax Margin % | - | - | - | - | - |
| Income Tax | -3.1M | 400K | 17.8M | -85.3M | 23.1M |
| Effective Tax Rate % | - | - | - | - | - |
| Net Income | 126.5M | 68.3M | 52.6M | 2.13B | 113.3M |
| Net Margin % | - | - | - | - | - |
| Net Income Growth % | - | -0.46% | -0.23% | 39.54% | -0.95% |
| EPS (Diluted) | 0.63 | 0.34 | 0.26 | 18.65 | 0.98 |
| EPS Growth % | - | -0.46% | -0.24% | 70.73% | -0.95% |
| EPS (Basic) | 0.65 | 0.35 | 0.27 | 18.65 | 0.98 |
| Diluted Shares Outstanding | 186.7M | 200.38M | 199.32M | 114.32M | 115.63M |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Total Assets | 5.32B | 7.05B | 8.31B | 10.03B | 11.77B |
| Asset Growth % | - | 0.33% | 0.18% | 0.21% | 0.17% |
| Total Investment Assets | 1.75B | 2.78B | 2.42B | 3.34B | 3.83B |
| Long-Term Investments | 1.64B | 2.53B | 2.31B | 3.29B | 3.63B |
| Short-Term Investments | 1.55B | 2.5B | 2.31B | 604.9M | 369.7M |
| Total Current Assets | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 967.2M | 325.1M | 1.22B | 712.4M | 743M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | -4.52B | -6.11B | -7.35B | -6.05B | -7.01B |
| Goodwill & Intangibles | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| PP&E (Net) | 9.8M | 29.9M | 26.8M | 0 | 0 |
| Other Assets | -1.65B | -2.56B | -2.33B | -3.29B | -3.63B |
| Total Liabilities | 3.34B | 5.03B | 6.33B | 7.58B | 9.32B |
| Total Debt | 456.5M | 478.3M | 476M | 448.2M | 448.9M |
| Net Debt | -510.7M | 153.2M | -746M | -264.2M | -294.1M |
| Long-Term Debt | 446M | 446.9M | 447.5M | 448.2M | 448.9M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 507.9M | 947.8M | 1.06B | 1.07B | 1.54B |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -507.9M | -947.8M | -1.06B | -1.41B | -1.93B |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | -456.5M | -478.3M | -476M | -448.2M | -448.9M |
| Total Equity | 1.98B | 2.02B | 1.99B | 2.45B | 2.45B |
| Equity Growth % | - | 0.02% | -0.02% | 0.23% | -0% |
| Shareholders Equity | 1.98B | 2.01B | 1.98B | 2.45B | 2.45B |
| Minority Interest | 0 | 5.2M | 10.3M | 0 | 0 |
| Retained Earnings | -120.4M | -52.1M | 500K | 436.6M | 503.6M |
| Common Stock | 2.1M | 1.9M | 1.9M | 1.2M | 1.2M |
| Accumulated OCI | 22.6M | -11.3M | -100.8M | -27M | 4.5M |
| Return on Equity (ROE) | 0.06% | 0.03% | 0.03% | 0.96% | 0.05% |
| Return on Assets (ROA) | 0.02% | 0.01% | 0.01% | 0.23% | 0.01% |
| Equity / Assets | - | - | - | - | - |
| Debt / Equity | 0.23x | 0.24x | 0.24x | 0.18x | 0.18x |
| Book Value per Share | 10.58 | 10.08 | 9.97 | 21.43 | 21.17 |
| Tangible BV per Share | - | - | - | - | - |
| Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|
| Cash from Operations | 316.1M | 345.8M | 741.4M | 495.2M | 618.2M |
| Operating CF Growth % | - | 0.09% | 1.14% | -0.33% | 0.25% |
| Operating CF / Revenue % | - | - | - | - | - |
| Net Income | 126.6M | 78.3M | 52.6M | 2.13B | 113.3M |
| Depreciation & Amortization | 2.6M | 4.5M | 3.9M | 300K | -14M |
| Stock-Based Compensation | 32.6M | 9.8M | 10.8M | 27.6M | 7.8M |
| Deferred Taxes | -6M | -26.4M | -10.4M | -86.5M | 9.8M |
| Other Non-Cash Items | -10.8M | 12M | 36M | -1.72B | 28.6M |
| Working Capital Changes | 171.1M | 267.6M | 648.5M | 137M | 472.7M |
| Cash from Investing | -481.3M | -1.09B | 215.9M | -834.9M | -475.8M |
| Capital Expenditures | -2M | -7.1M | -18.8M | -6.4M | -4.6M |
| Acquisitions | 0 | -7.1M | 0 | 0 | 0 |
| Purchase of Investments | -1.27B | -2.25B | -1.71B | -2.24B | -2.52B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | 0 | 7.1M | 15.7M | 0 | 0 |
| Cash from Financing | 948M | -18.2M | -16.2M | -106.9M | -153.9M |
| Dividends Paid | -5.1M | -2.1M | -500K | 0 | -46.2M |
| Share Repurchases | 0 | -320.9M | 0 | 0 | -105.5M |
| Stock Issued | 691.8M | 318.2M | 0 | 89.4M | 0 |
| Debt Issuance (Net) | 1000K | 0 | 0 | 0 | 0 |
| Other Financing | -600K | -13.4M | -15.7M | -196.3M | -2.2M |
| Net Change in Cash | 787.6M | -762.5M | 931.9M | -443.8M | -17.5M |
| Exchange Rate Effect | 1000K | -1000K | -1000K | 1000K | -1000K |
| Cash at Beginning | 450.9M | 1.24B | 476M | 1.41B | 964.1M |
| Cash at End | 1.24B | 476M | 1.41B | 964.1M | 946.6M |
| Free Cash Flow | 314.1M | 338.7M | 722.6M | 488.8M | 613.6M |
| FCF Growth % | - | 0.08% | 1.13% | -0.32% | 0.26% |
| FCF Margin % | - | - | - | - | - |
| FCF per Share | 1.68 | 1.69 | 3.63 | 4.28 | 5.31 |
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Combined Ratio | 84.22% | 93.41% | 94.72% | 43.01% | 94.37% |
| Medical Cost Ratio | 64.36% | 79.28% | 0% | 39.6% | 89.01% |
| Return on Equity (ROE) | 6.4% | 3.42% | 2.63% | 96.13% | 4.63% |
| Return on Assets (ROA) | 2.38% | 1.1% | 0.68% | 23.25% | 1.04% |
| Equity / Assets | 37.14% | 28.63% | 23.9% | 24.43% | 20.81% |
| Book Value / Share | 10.58 | 10.08 | 9.97 | 21.43 | 21.17 |
| Debt / Equity | 0.23x | 0.24x | 0.24x | 0.18x | 0.18x |
| Revenue Growth | - | 52.62% | 26.94% | 136.91% | -32.59% |
| 2023 | 2024 | |
|---|---|---|
| Insurance | - | 1.9B |
| Insurance Growth | - | - |
| Reinsurance | 253.7M | 355.7M |
| Reinsurance Growth | - | 40.20% |
| Specialty | 1.2B | - |
| Specialty Growth | - | - |
Fidelis Insurance Holdings Limited (FIHL) has a price-to-earnings (P/E) ratio of 19.0x. This is roughly in line with market averages.
Fidelis Insurance Holdings Limited (FIHL) saw revenue decline by 32.6% over the past year.
Fidelis Insurance Holdings Limited (FIHL) reported a net loss of $14.5M for fiscal year 2024.
Yes, Fidelis Insurance Holdings Limited (FIHL) pays a dividend with a yield of 2.15%. This makes it attractive for income-focused investors.
Fidelis Insurance Holdings Limited (FIHL) has a return on equity (ROE) of 4.6%. This is below average, suggesting room for improvement.
Fidelis Insurance Holdings Limited (FIHL) has a combined ratio of 94.4%. A ratio below 100% indicates underwriting profitability.